Is Isracard (TASE:ISCD) A Bargain After Ending Its Esh Bank Deal?

Isracard (TASE:ISCD) has terminated its planned acquisition of Israeli digital lender Esh Bank after the memorandum of understanding expired without a binding agreement, ending a proposed deal reportedly valued at up to NIS 500 million.

See our latest analysis for Isracard.

Isracard shares closed at ₪11.15 after a 1 day share price gain of 3.24%. However, recent momentum has been weak, with the 30 day share price return down 7.78% and the 1 year total shareholder return declining 30.63%, even though the 5 year total shareholder return is up 42.83%.

If this sort of volatility has you looking wider than a single financial stock, it could be a good moment to scan the market using our 106 top founder-led companies

Isracard has a large cards business, recent share price weakness, and a cancelled bank deal that raises fresh questions about execution. The key issue now is simpler: is the stock already cheap enough to reflect all of that?

Preferred Price-to-Sales of 1.1x: Is it justified?

On price-to-sales, Isracard trades on about 1.1x revenue, while its shares most recently closed at ₪11.15. Compared with similar consumer finance companies, that multiple sits at a marked discount.

P/S compares the company’s market value with its annual revenue, so a lower ratio can sometimes indicate that the market is assigning a lower value per shekel of sales. For Isracard, this sits alongside a loss of ₪2 million on ₪3,300 million of revenue and a period where earnings have declined on average over the past five years.

Against that backdrop, the market is pricing Isracard at a far lower P/S than both the Asian consumer finance industry average of 3.1x and its closer peer group at 3.6x. That gap highlights how cautiously investors are currently valuing each unit of Isracard’s revenue relative to similar businesses.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price-to-Sales of 1.1x (UNDERVALUED)

Alongside the P/S view, the SWS DCF model estimates the value of Isracard’s future cash flows at about ₪5.07 per share, compared with the recent market price of ₪11.15. This framework projects future cash flows and discounts them back using a required return, so it is sensitive to both growth assumptions and risk.

For a business that is currently loss making, with debt that is not well covered by operating cash flow and earnings that have declined over several years, a cash flow based lens can often paint a different picture to a simple sales multiple. Here, it points to a situation where the market price sits well above that DCF estimate.

Look into how the SWS DCF model arrives at its fair value.

Result: DCF Fair value of ₪5.07 (OVERVALUED)

However, Isracard still faces risks from its recent loss on ₪3,300 million of revenue and the cancelled Esh Bank deal, which may pressure investor confidence.

Find out about the key risks to this Isracard narrative.

Another view on Isracard’s value

The earlier discussion showed Isracard looking inexpensive on its 1.1x P/S, but the SWS DCF model tells a very different story. Using this approach, estimated fair value sits around ₪5.07 per share, well below the recent price of ₪11.15. On this basis, the stock screens as overvalued relative to its cash flows.

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Isracard for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 233 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If this assessment of Isracard feels mixed to you, use that as a prompt to review the figures, weigh the uncertainties, and decide how serious the 3 important warning signs is for your own investment view.

Looking for more investment ideas beyond Isracard?

Do not stop with Isracard. Broader context across sectors and styles can sharpen your judgment and help you spot opportunities others ignore.

• Target potential mispricings by reviewing companies that screen as attractively valued on quality and price through our carefully curated list of 233 high quality undervalued stocks.
• Prioritize resilience by scanning stocks that pair financial strength with solid fundamentals using the focused solid balance sheet and fundamentals stocks screener (420 results).
• Hunt for overlooked opportunities by zeroing in on financially sound businesses that the market has not crowded yet through the screener containing 515 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com